FDA Inspection 1312130 — Susan Halimeh, M.D., PhD
The FDA completed an inspection of Susan Halimeh, M.D., PhD on Apr 1, 2026 in Duisburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 1, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Duisburg (Germany)
Additional details
Clinical Investigator (CI)